Our Dynamic Purchasing System (DPS) is an innovative procurement process we have developed to streamline and accelerate access to cutting-edge medical technologies.
The DPS ensures suppliers and NHS organisations collaborate effectively, bringing innovative solutions to patients faster and more efficiently.
This diversity allows NHS trusts to find tailored solutions that align with their clinical and operational needs, driving improved outcomes for patients and staff.
Register your interest in these innovative and game-changing products by completing a product specific expression of interest form below.
WID-easy supplied by Advanced Global Health Ltd.
This briefing introduces a disruptive innovation newly available via NHS Supply Chain: WID-easy.
Reviewed by clinical specialists and supported by key stakeholders, this device offers a novel approach to accurately triage peri-menopausal and post-menopausal women with abnormal uterine bleeding.
iFAST – Rapid antimicrobial susceptibility testing
This briefing introduces a disruptive innovation newly available via NHS Supply Chain: iFAST.
Reviewed by clinical specialists and supported by key stakeholders, this device offers a novel approach to rapid antimicrobial susceptibility testing directly from positive blood cultures or isolated bacterial colonies.
LVOne supplied by Pockit Diagnostics Ltd.
LVOne is a a rapid blood test to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. .
LumenEye® supplied by Surgease Innovations Ltd
Innovative digital proctoscopy for improved patient care.
Only the consumable element is covered by the innovation – not the capital equipment.
Sonata supplied by Hologic Inc.
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids.
All products available via eDirect route with Manufacturer Product Code (MPC) shown.
Tensi+ supplied by Clinimed Ltd.
Helping patients regain bladder control: innovative therapy for overactive bladder.
Centauri supplied by Cardiofocus, Inc.
Advanced laser balloon technology for managing cardiac arrhythmias by using Pulsed Field Ablation (PFA) to create ablation lesions.






















